Featured Research

from universities, journals, and other organizations

Pitt Researchers Identify Biomarkers Of Lupus Which Could Lead To Quicker And Better Diagnosis

Date:
November 9, 2004
Source:
University Of Pittsburgh Medical Center
Summary:
University of Pittsburgh researchers have identified biomarkers that could result in earlier and more accurate diagnosis of systemic lupus erythematosus (SLE), a devastating disease that affects as many as 1.5 million Americans, and occurs 10 to 15 times more frequently in women.

PITTSBURGH, Nov. 4 – University of Pittsburgh researchers have identified biomarkers that could result in earlier and more accurate diagnosis of systemic lupus erythematosus (SLE), a devastating disease that affects as many as 1.5 million Americans, and occurs 10 to 15 times more frequently in women.

The results are published in the November 2004 issue of Arthritis & Rheumatism.

"This is the first report of abnormal levels of the protein erythrocyte-C4d in human disease," said lead author Susan Manzi, M.D., M.P.H., associate professor of medicine, epidemiology and dermatology at the University of Pittsburgh School of Medicine and the University of Pittsburgh Graduate School of Public Health. "Abnormally high levels of erythrocyte-C4d and low levels of erythrocyte-CR1 are characteristic of SLE and combined measurement of the two proteins has high diagnostic sensitivity and specificity for lupus."

The significance of the finding is substantial, according to Joseph Ahearn, M.D., associate professor of medicine at the University of Pittsburgh School of Medicine and senior author of the study.

"Today we are one step closer to providing patients with an immediate and accurate diagnosis, one step closer to providing physicians with the ability to offer better treatment options and one step closer to providing incentive to lower the cost of health care for patients suffering from lupus," Dr. Ahearn said.

"Lupus is the prototypical autoimmune disease and arguably the greatest diagnostic challenge among rheumatologic diseases," he said. "The spectrum of disease among patients with SLE is broad and ranges from subtle or vague symptoms to life-threatening multiorgan failure, and the manifestations of lupus often mimic those of other diseases makes it difficult to diagnose."

It is not unusual for a patient with lupus to seek advice from a variety of specialists and subspecialists over a period of years before being accurately diagnosed, which results in delays in receiving proper therapy and an ultimately greater cost for treating the disease and its complications. Although there is no cure for lupus, there are many ways to treat symptoms, including chemotherapy.

Currently, most physicians rely on blood abnormalities to aid in the diagnosis of SLE, but according to Dr. Manzi, these tests are inadequate because they are not sensitive or specific enough.

In the study, researchers used blood samples taken from each participant and analyzed them using flow cytometry to compare the levels of proteins in 100 patients who were confirmed to have lupus, 133 patients who had other diseases and conditions including myositis, systemic sclerosis, hepatitis and rheumatoid arthritis, and 84 healthy patients.

Lupus is a widespread and chronic autoimmune disease that, for unknown reasons, causes the immune system to attack the body's own tissue and organs, including the joints, kidneys, heart, lungs, brain, blood and skin.

The immune system normally protects the body against viruses, bacteria and other foreign materials. In an autoimmune disease like lupus, the immune system loses its ability to tell the difference between foreign substances and its own cells and tissue. The immune system then makes antibodies directed against itself.

###

The study was supported by grants from the National Institutes of Health, the Lupus Foundation of Pennsylvania, the Alliance for Lupus Research, the Lupus Foundation America, Southeastern Pennsylvania Chapter and the National Arthritis Foundation.


Story Source:

The above story is based on materials provided by University Of Pittsburgh Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Pittsburgh Medical Center. "Pitt Researchers Identify Biomarkers Of Lupus Which Could Lead To Quicker And Better Diagnosis." ScienceDaily. ScienceDaily, 9 November 2004. <www.sciencedaily.com/releases/2004/11/041108030738.htm>.
University Of Pittsburgh Medical Center. (2004, November 9). Pitt Researchers Identify Biomarkers Of Lupus Which Could Lead To Quicker And Better Diagnosis. ScienceDaily. Retrieved August 29, 2014 from www.sciencedaily.com/releases/2004/11/041108030738.htm
University Of Pittsburgh Medical Center. "Pitt Researchers Identify Biomarkers Of Lupus Which Could Lead To Quicker And Better Diagnosis." ScienceDaily. www.sciencedaily.com/releases/2004/11/041108030738.htm (accessed August 29, 2014).

Share This




More Health & Medicine News

Friday, August 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Killer Amoeba Found in Louisiana Water System

Killer Amoeba Found in Louisiana Water System

AP (Aug. 28, 2014) State health officials say testing has confirmed the presence of a killer amoeba in a water system serving three St. John the Baptist Parish towns. (Aug. 28) Video provided by AP
Powered by NewsLook.com
Who Could Be Burnt by WHO's E-Cigs Move?

Who Could Be Burnt by WHO's E-Cigs Move?

Reuters - Business Video Online (Aug. 28, 2014) The World Health Organisation has called for the regulation of electronic cigarettes as both tobacco and medical products. Ciara Lee looks at the impact of the move on the tobacco industry. Video provided by Reuters
Powered by NewsLook.com
CDC Director On Ebola Outbreak: 'It's Worse Than I Feared'

CDC Director On Ebola Outbreak: 'It's Worse Than I Feared'

Newsy (Aug. 28, 2014) CDC director Tom Frieden says the Ebola outbreak is even worse than he feared. But he also said there's still hope to contain it. Video provided by Newsy
Powered by NewsLook.com
Amid Grave Ebola Estimates, US to Test Vaccine

Amid Grave Ebola Estimates, US to Test Vaccine

AP (Aug. 28, 2014) The National Institutes of Health will start the first human safety trials of an experimental Ebola vaccine next week, amid a grave estimate from the World Health Organization that Ebola cases in West Africa could top 20,000. (Aug. 28) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins